Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
A Randomized, Double-Blind Phase 3 Study of Ibrutinib in Combination With Corticosteroids versus Placebo in Combination With Corticosteroids in Subjects with New Onset Chronic Graft Versus Host Disease (cGVHD) (PCYC-1140-IM)
Study Status:
Open to Enrollment
Primary Investigator:
Tsiporah Shore, M.D.
Date: March 6, 2018
An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant
Study Status:
Open to Enrollment
Primary Investigator:
Tsiporah Shore, M.D.
Date: March 6, 2018
CPX-351 as Salvage Chemotherapy Followed by a Reduced Intensity Conditioning (RIC) Stem Cell Transplantation Utilizing Double Umbilical Cord Blood (dUCB) Grafts for Patients with Relapsed or Refractory Leukemia
Study Status:
Open to Enrollment
Primary Investigator:
Usama Gergis, M.D.
Date: September 22, 2015
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves
Study Status:
Open to Enrollment
Primary Investigator:
Wong, Sing-Chiu M.D.
Date: September 22, 2015
A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Study Status:
Open to Enrollment
Primary Investigator:
Wong, Sing-Chiu M.D.
Date: September 22, 2015
A Phase 1 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors
Study Status:
Open to Enrollment
Primary Investigator:
Yariv Houvras, MD, PhD
Date: December 12, 2018
MRI method for quantitatively mapping cerebral microbleeds
Study Status:
Open to Enrollment
Primary Investigator:
Yi Wang
Date: January 5, 2017
In vitro maturation (IVM) of human oocytes
Study Status:
Open to Enrollment
Primary Investigator:
Zev Rosenwaks, M.D.
Date: January 5, 2017